Algo version: 0.98b
Eurofins-Cerep SA is listed at the EURONEXT Exchange
Eurofins-Cerep SA [ALECR.PA]
EURONEXT Sector: Healthcare Industry:Medical - Diagnostics & Research

Is Eurofins-Cerep SA stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Eurofins-Cerep SA 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was €6 300.00, you would have made a profit of €14 900 per share or 236.51%

We do not have enough data to give you this answer.

Eurofins-Cerep SA has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 283.27, the company's ability to pay off the debt is good. Eurofins-Cerep SA has a good net profit margin of 17.33% and should have high tolerances against inflation.

We have calculated the inflation risk for Eurofins-Cerep SA to be low [0.1 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.